Publicaciones en las que colabora con Alvaro Ruibal Morell (16)

2024

  1. Quantitative brain [18F]FDG PET beyond normal blood glucose levels

    NeuroImage, Vol. 300

2021

  1. Feasibility of Longitudinal Brain PET with Real-Time Arterial Input Function in Rats

    Molecular Imaging and Biology, Vol. 23, Núm. 3, pp. 350-360

2020

  1. -FMISO PET/MRI Imaging Shows Ischemic Tissue around Hematoma in Intracerebral Hemorrhage

    Molecular Pharmaceutics, Vol. 17, Núm. 12, pp. 4667-4675

  2. 3D printed tacrolimus rectal formulations ameliorate colitis in an experimental animal model of inflammatory bowel disease

    Biomedicines, Vol. 8, Núm. 12, pp. 1-19

  3. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 154, pp. 330-337

2019

  1. Evaluation of the therapeutic activity of melatonin and resveratrol in Inflammatory Bowel Disease: A longitudinal PET/CT study in an animal model

    International Journal of Pharmaceutics, Vol. 572

  2. Ocular bio distribution studies using molecular imaging

    Pharmaceutics, Vol. 11, Núm. 5

  3. Prediction of Alzheimer's disease dementia with MRI beyond the short-term: Implications for the design of predictive models

    NeuroImage: Clinical, Vol. 23

  4. Staging the cognitive continuum in prodromal Alzheimer's disease with episodic memory

    Neurobiology of Aging, Vol. 84, pp. 1-8

2018

  1. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model

    International Journal of Pharmaceutics, Vol. 549, Núm. 1-2, pp. 335-342

  2. Preclinical characterization and clinical evaluation of tacrolimus eye drops

    European Journal of Pharmaceutical Sciences, Vol. 120, pp. 152-161

  3. Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 45, Núm. 2, pp. 196-206

2017

  1. In vivo eye surface residence determination by high-resolution scintigraphy of a novel ion-sensitive hydrogel based on gellan gum and kappa-carrageenan

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 114, pp. 317-323

  2. Positron emission tomography for the development and characterization of corneal permanence of ophthalmic pharmaceutical formulations

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 2, pp. 772-780

  3. Preclinical PET study of intravitreal injections

    Investigative Ophthalmology and Visual Science, Vol. 58, Núm. 7, pp. 2843-2851

2016

  1. Impact of benzodiazepines on brain FDG-PET quantification after single-dose and chronic administration in rats

    Nuclear Medicine and Biology, Vol. 43, Núm. 12, pp. 827-834